Literature DB >> 27288533

Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade.

Isabel Vogel1, Bert Verbinnen1, Stefaan Van Gool2, Jan L Ceuppens3.   

Abstract

Blocking of costimulatory CD28/B7 and CD40/CD40L interactions is an experimental approach to immune suppression and tolerance induction. We previously reported that administration of a combination of CTLA-4Ig and MR1 (anti-CD40L mAb) for blockade of these interactions induces tolerance in a fully mismatched allogeneic splenocyte transfer model in mice. We now used this model to study whether regulatory T cells (Tregs) contribute to immune suppression and why both pathways have to be blocked simultaneously. Mice were injected with allogeneic splenocytes, CD4(+) T cells, or CD8(+) T cells and treated with MR1 mAb and different doses of CTLA-4Ig. The graft-versus-host reaction of CD4(+) T cells, but not of CD8(+) T cells, was inhibited by MR1. CTLA-4Ig was needed to cover CD8(+) T cells but had only a weak effect on CD4(+) T cells. Consequently, only the combination provided full protection when splenocytes were transferred. Importantly, MR1 and low-dose CTLA-4Ig treatment resulted in a relative increase in Tregs, and immune suppressive efficacy was abolished in the absence of Tregs. High-dose CTLA-4Ig treatment, in contrast, prevented Treg expansion and activity, and in combination with MR1 completely inhibited CD4(+) and CD8(+) T cell activation in a Treg-independent manner. In conclusion, MR1 and CTLA-4Ig act synergistically as they target different T cell populations. The contribution of Tregs to immune suppression by costimulation blockade depends on the concentration of CTLA-4Ig and thus on the degree of available CD28 costimulation.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27288533     DOI: 10.4049/jimmunol.1502039

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients.

Authors:  S Bigenzahn; B Juergens; B Mahr; J Pratschke; A Koenigsrainer; T Becker; D Fuchs; G Brandacher; A Kainz; F Muehlbacher; T Wekerle
Journal:  Clin Exp Immunol       Date:  2018-02-02       Impact factor: 4.330

2.  Neutralization of CD40 ligand costimulation promotes bone formation and accretion of vertebral bone mass in mice.

Authors:  Susanne Roser-Page; Tatyana Vikulina; Kanglun Yu; Meghan E McGee-Lawrence; M Neale Weitzmann
Journal:  Rheumatology (Oxford)       Date:  2018-06-01       Impact factor: 7.580

3.  CD4 Depletion or CD40L Blockade Results in Antigen-Specific Tolerance in a Red Blood Cell Alloimmunization Model.

Authors:  Prabitha Natarajan; Dong Liu; Seema R Patel; Manjula Santhanakrishnan; Daniel Beitler; Jingchun Liu; David R Gibb; Justine S Liepkalns; David J Madrid; Stephanie C Eisenbarth; Sean R Stowell; Jeanne E Hendrickson
Journal:  Front Immunol       Date:  2017-08-07       Impact factor: 7.561

4.  Control of Treg cell homeostasis and immune equilibrium by Lkb1 in dendritic cells.

Authors:  Song Chen; Lijun Fang; Wei Guo; Yushan Zhou; Gang Yu; Wenwen Li; Kui Dong; Jingru Liu; Yuechen Luo; Bing Wang; Zhonglong Li; Chunxiao Zhao; Zhina Sun; Yue Shen; Qibing Leng; Dongming Zhou; Zhongchao Han; Huifang Huang; He Ren; Guogang Xu; Xiaoming Feng
Journal:  Nat Commun       Date:  2018-12-13       Impact factor: 14.919

5.  CTLA-4Ig Improves Hyperalgesia in a Mouse Model of Osteoporosis.

Authors:  Nobuto Nagao; Hiroki Wakabayashi; Gaku Miyamura; Sho Kato; Yohei Naito; Akihiro Sudo
Journal:  Int J Mol Sci       Date:  2020-12-13       Impact factor: 5.923

Review 6.  The Costimulatory Pathways and T Regulatory Cells in Ischemia-Reperfusion Injury: A Strong Arm in the Inflammatory Response?

Authors:  Laura de Ramon; Jordi Guiteras; Roser Guiteras; Josep M Cruzado; Josep M Grinyó; Juan Torras
Journal:  Int J Mol Sci       Date:  2018-04-25       Impact factor: 5.923

Review 7.  The Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens.

Authors:  Jose-Ignacio Rodriguez-Barbosa; Pascal Schneider; Luis Graca; Leo Bühler; Jose-Antonio Perez-Simon; Maria-Luisa Del Rio
Journal:  Int J Mol Sci       Date:  2020-05-09       Impact factor: 5.923

8.  Deficiency of T cell CD40L has minor beneficial effects on obesity-induced metabolic dysfunction.

Authors:  Suzanne A B M Aarts; Esther Lutgens; Myrthe E Reiche; Myrthe den Toom; Lisa Willemsen; Bram van Os; Marion J J Gijbels; Norbert Gerdes
Journal:  BMJ Open Diabetes Res Care       Date:  2019-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.